Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
- Status
- WITHDRAWN
- Phase
- NA
Phase II Efficacy Study of AZD6244 in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China
- Status
- TERMINATED
- Phase
- PHASE3
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Proton Therapy With Capecitabine for Rectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1